These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18412260)

  • 1. Low recurrence of preexisting extrahepatic malignancies after liver transplantation.
    Benten D; Sterneck M; Panse J; Rogiers X; Lohse AW
    Liver Transpl; 2008 Jun; 14(6):789-98. PubMed ID: 18412260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states.
    Saigal S; Norris S; Srinivasan P; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2001 Jan; 7(1):11-5. PubMed ID: 11150415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent nonhepatic and de novo malignancies after liver transplantation.
    Jain A; Fiaz O; Sheikh B; Sharma R; Safadjou S; Kashyap R; Bryan L; Batzold P; Orloff M
    Transplantation; 2009 Sep; 88(5):706-10. PubMed ID: 19741469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of de novo neoplasms after liver transplantation].
    Berenguer M; Prieto M; Bustamante M; Carrasco D; López-Andújar R; Mir J; Berenguer J
    Med Clin (Barc); 1998 Oct; 111(13):481-4. PubMed ID: 9859063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caroli's disease and orthotopic liver transplantation.
    Habib S; Shakil O; Couto OF; Demetris AJ; Fung JJ; Marcos A; Chopra K
    Liver Transpl; 2006 Mar; 12(3):416-21. PubMed ID: 16498655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
    Cruz E; Ascher NL; Roberts JP; Bass NM; Yao FY
    Clin Transplant; 2005 Aug; 19(4):501-6. PubMed ID: 16008595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in the setting of extra-hepatic malignancy: two case reports.
    Fayek S; Moore D; Bortecen KH; Yeh H; Markmann JF; Olthoff KM; Shaked A
    Transplant Proc; 2007 Dec; 39(10):3512-4. PubMed ID: 18089424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of de novo neoplasia after liver transplantation.
    Xiol X; Guardiola J; Menendez S; Lama C; Figueras J; Marcoval J; Serrano T; Botargues JM; Mañer M; Rota R
    Liver Transpl; 2001 Nov; 7(11):971-5. PubMed ID: 11699033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
    Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
    Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases.
    Jiménez-Romero C; Manrique Municio A; Marqués Medina E; Colina F; Ortega Domene P; Gómez Sanz R; Meneu Diaz JC; Abradelo de Usera M; Moreno Elola A; Moreno Gonzalez E
    Transplant Proc; 2006 Oct; 38(8):2505-7. PubMed ID: 17097982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center experience of retransplantation for liver transplant recipients with a failing graft.
    Chen GH; Fu BS; Cai CJ; Lu MQ; Yang Y; Yi SH; Xu C; Li H; Wang GS; Zhang T
    Transplant Proc; 2008 Jun; 40(5):1485-7. PubMed ID: 18589134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy after liver transplantation: cumulative risk for development.
    Marqués Medina E; Jiménez Romero C; Gómez de la Cámara A; Rota Bernal A; Manrique Municio A; Moreno González E
    Transplant Proc; 2009; 41(6):2447-9. PubMed ID: 19715947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
    Molmenti EP; Netto GJ; Murray NG; Smith DM; Molmenti H; Crippin JS; Hoover TC; Jung G; Marubashi S; Sanchez EQ; Gogel B; Levy MF; Goldstein RM; Fasola CG; Gonwa TA; Klintmalm GB
    Liver Transpl; 2002 Jun; 8(6):519-26. PubMed ID: 12037782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.